# COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study

> **NCT04385069** · — · UNKNOWN · sponsor: **University College, London** · enrollment: 500 (estimated)

## Conditions studied

- COV-HI
- COVID-19
- COVID-19 (COV) Hyperinflammatory (HI) Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04385069
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-16
- **Primary completion:** 2020-07-05
- **Final completion:** 2020-07-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385069, "COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04385069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*